| |
| |
|
| Insider
Information: |
Hombach Robert J. |
| Relationship: |
Director |
| City: |
Deerfield |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
373,237 |
|
|
Indirect Shares
|
12,064 |
|
|
| Direct
Value |
$6,856,109 |
|
|
|
Indirect Value
|
$85,440 |
|
|
| Total
Shares |
385,301 |
|
|
| Total
Value |
$6,941,549 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -51.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Baxter International Inc |
BAX |
Corporate Vice President |
2015-03-03 |
80,967 |
2011-01-19 |
2,064 |
Premium* |
|
|
Baxalta Inc |
BXLT |
EVP. CFO and COO |
2016-06-03 |
0 |
2015-07-01 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2023-05-23 |
30,500 |
2017-09-29 |
0 |
Premium* |
|
|
Aptinyx Inc. |
APTX |
|
2021-11-12 |
229,100 |
2021-11-12 |
10,000 |
Premium* |
|
|
CarMax Inc |
KMX |
Director |
2021-07-02 |
7,766 |
2018-06-29 |
0 |
Premium* |
|
|
Embecta Corp. |
EMBC |
Director |
2024-02-07 |
24,904 |
2022-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EMBC |
Embecta Corp. |
Director |
– • – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
11,455 |
24,904 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,190 |
30,500 |
0 |
- |
|
| EMBC |
Embecta Corp. |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,979 |
13,075 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,980 |
26,310 |
0 |
- |
|
| EMBC |
Embecta Corp. |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,024 |
6,024 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
|
– • – |
2021-11-12 |
4 |
B |
$2.40 |
$179,040 |
D/D |
74,600 |
219,100 |
0.01 |
- |
|
| APTX |
Aptinyx Inc. |
|
– • – |
2021-11-12 |
4/A |
B |
$2.40 |
$179,040 |
D/D |
74,600 |
229,100 |
0.01 |
- |
|
| APTX |
Aptinyx Inc. |
|
– • – |
2021-11-11 |
4/A |
B |
$2.40 |
$12,960 |
D/D |
5,400 |
154,500 |
0.01 |
- |
|
| APTX |
Aptinyx Inc. |
|
– • – |
2021-11-11 |
4 |
B |
$2.40 |
$12,960 |
D/D |
5,400 |
144,500 |
0.01 |
% |
|
| KMX |
CarMax Inc |
Director |
– • – |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,308 |
7,766 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,120 |
21,330 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2020-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,300 |
16,210 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
Director |
– • – |
2020-01-10 |
4 |
B |
$3.00 |
$150,000 |
D/D |
50,000 |
139,100 |
2.39 |
% |
|
| APTX |
Aptinyx Inc. |
Director |
– • – |
2019-11-22 |
4 |
B |
$3.24 |
$161,750 |
D/D |
50,000 |
89,100 |
2.39 |
- |
|
| KMX |
CarMax Inc |
Director |
– • – |
2019-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,020 |
4,437 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2019-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,430 |
11,910 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
Director |
– • – |
2019-01-25 |
4 |
B |
$5.54 |
$64,569 |
D/D |
11,655 |
49,100 |
2.39 |
- |
|
| APTX |
Aptinyx Inc. |
Director |
– • – |
2019-01-24 |
4 |
B |
$5.52 |
$73,664 |
D/D |
13,345 |
37,445 |
2.39 |
- |
|
| KMX |
CarMax Inc |
Director |
– • – |
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,390 |
2,417 |
0 |
- |
|
| APTX |
Aptinyx Inc. |
Director |
– • – |
2018-06-25 |
4 |
B |
$16.00 |
$385,600 |
D/D |
24,100 |
24,100 |
2.39 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2018-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,300 |
7,480 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
3,180 |
3,180 |
0 |
- |
|
| BXLT |
Baxalta Inc |
EVP. CFO and COO |
• – – |
2016-06-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(209,089) |
0 |
0 |
- |
|
| BXLT |
Baxalta Inc |
EVP. CFO and COO |
• – – |
2016-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
16,356 |
209,089 |
0 |
- |
|
| BXLT |
Baxalta Inc |
EVP, CFO and COO |
• – – |
2016-03-03 |
4 |
D |
$39.30 |
$231,870 |
D/D |
(5,900) |
192,464 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
